Dr. Shuhao Zhang, MD

Dr. Zhang practices at Mercy Medical Group, a Service of Dignity Health Medical Foundation in Sacramento, California.

Dr. Zhang's NPI, 1497075980, was assigned on June 7, 2010. Dr. Zhang graduated from Drexel University College Of Medicine in 2010. Dr. Zhang holds California license A160657.

Dr. Zhang's primary practice is Mercy Medical Group, a Service of Dignity Health Medical Foundation, at 3000 Q St, Sacramento, CA 95816 in Sacramento County. The practice phone is (916) 733-3397.

Dr. Zhang's primary practice is Mercy Medical Group, a Service of Dignity Health Medical Foundation in Sacramento, California. Dr. Zhang is also affiliated with Dignity Health - Mercy General Hospital. The medical group on file is Mercy Medical Group. Dmand AI also links Dr. Zhang to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zhang practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Zhang's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Zhang is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Zhang's licenses on file in 3 states: California, Texas and Virginia.

Dmand AI lists breast reconstruction, breast surgery and removal of damaged skin or skin graft among the conditions Dr. Zhang treats.

CMS data shows 78 Medicare services from Dr. Zhang across 4 procedure codes in 2024, all of them office visits, for 86 Medicare patients. Medicare paid $6,185 for them. Every service was in an office.

CMS counts 86 Medicare patients who saw Dr. Zhang in 2024. The largest group is 65 to 74, with 59 patients. 75% of them have high cholesterol, and 65% have cancer. 27% are also on Medicaid. Their average risk score is 0.96, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zhang's median patient age at 54, with 89% women.

In 2024, Dr. Zhang wrote 28 Medicare Part D claims for 15 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $32 in total drug cost. In 2023, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Zhang for performance year 2024, reported through an alternative payment model (APM). Dr. Zhang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of mastectomy by Dr. Zhang, more than 87% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 10 papers to Dr. Zhang, published from 2015 to 2025. 2025 was the busiest year, with 2. Dr. Zhang has published most often in Plast Reconstr Surg Glob Open. Dr. Zhang's most frequent co-authors are Nadia P. Blanchet, MD, Christina Wen Ching, MD and Austin Hembd.

CMS Open Payments shows 33 general payments to Dr. Zhang from 9 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 46% of the total. AxoGen paid the most, $2,848.

Dr. Zhang graduated from Drexel University College Of Medicine in 2010.

Dr. Zhang is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.